A historic shift in federal drug policy is underway. Following an executive order signed on December 18, 2025, the Trump administration has directed an expedited move to reclassify cannabis from Schedule I to Schedule III. This monumental decision is set to reshape the industry by dismantling long-standing financial barriers and introducing first-of-its-kind federal healthcare support for cannabinoid therapies.
President Donald Trump has publicly confirmed that his administration is “considering” an executive order to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. Speaking to reporters on December 15, Trump stated, “We are looking at that very strongly,” according to Cannabis Business Times. This announcement follows last week’s reports of a […]
What Every Business Needs to Know January 1, 2026 marks a pivotal moment for Michigan’s cannabis industry as the controversial 24% wholesale tax takes effect, fundamentally reshaping the economics of the state’s second-largest cannabis market in the nation. The New Tax Landscape Michigan cannabis businesses face a seismic shift in their operating environment with the […]
What Businesses Need to Know About the New Framework Virginia lawmakers have taken a decisive step toward launching the South’s first recreational cannabis market, unveiling a revised framework that could see adult-use sales begin by November 2026. The proposal, detailed by the Virginia Mercury, represents a significant shift from previous attempts and includes several provisions designed […]
The cannabis industry faces another regulatory paradox. The Centers for Medicare & Medicaid Services (CMS) has proposed allowing Medicare Advantage plans to cover hemp-derived CBD products starting in 2027, potentially opening insurance reimbursement for millions of seniors. Yet this potential coverage window arrives just as a separate federal law threatens to make many of those same […]
On December 12, 2025, the U.S. Supreme Court will meet behind closed doors to decide if it will hear Canna Provisions v. Bondi, a case that asks a simple but powerful question: can the federal government keep enforcing cannabis prohibition inside state legal markets? For cannabis operators, this is not an abstract constitutional debate. It sits […]
Hemp-derived THC products like delta-8 and infused seltzers have become wellness staples, but a federal ban may soon change that. This post breaks down what the legislation targets, how it could affect cannabis businesses and consumers, and what comes next for hemp’s legal future.
Your cannabis business directory listing could be costing you customers right now, and you might not even know it. Most dispensary owners think they’ve got their CannaMapr listing dialed in, but some sneaky mistakes can seriously hurt your visibility and credibility with potential customers. Let’s dive into the seven biggest mistakes cannabis businesses make with […]
Cannabis Product Trends in New Jersey for 2025.
Looking for high-quality legal weed in New York City? Our guide to the best dispensaries in NYC highlights top licensed shops offering everything from edibles and vapes to pre-rolls and concentrates. Whether you're a local or visiting, discover where to find trusted cannabis dispensaries with great products, knowledgeable staff, and unbeatable vibes.